(-0.55%) 5 079.50 points
(-0.30%) 38 565 points
(-0.92%) 17 502 points
(0.05%) $82.85
(-1.39%) $1.630
(0.06%) $2 339.70
(0.40%) $27.46
(0.25%) $918.10
(-0.23%) $0.932
(-0.32%) $10.95
(-0.46%) $0.799
(-0.27%) $92.07
@ $39.35
Issued: 24 Apr 2024 @ 13:31
Return: 1.52%
Previous signal: Apr 23 - 14:31
Previous signal:
Return: -1.87 %
Live Chart Being Loaded With Signals
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States...
Stats | |
---|---|
Today's Volume | 764 060 |
Average Volume | 1.42M |
Market Cap | 2.19B |
EPS | $0 ( 2024-03-26 ) |
Next earnings date | ( $-0.530 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -17.76 |
ATR14 | $2.53 (6.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-10 | Young Joseph R | Sell | 5 714 | Class A Common Stock |
2024-04-03 | Grant Sean | Buy | 99 828 | Class A Common Stock |
2024-04-03 | Grant Sean | Sell | 69 831 | Class A Common Stock |
2024-04-03 | Grant Sean | Sell | 10 988 | Class A Common Stock |
2024-04-03 | Grant Sean | Sell | 99 828 | Stock Option (right to buy) |
INSIDER POWER |
---|
32.86 |
Last 98 transactions |
Buy: 7 469 518 | Sell: 2 159 720 |
Volume Correlation
Vera Therapeutics, Inc. Correlation
10 Most Positive Correlations | |
---|---|
LCAP | 0.928 |
VTIP | 0.912 |
CYTO | 0.907 |
PAIC | 0.896 |
MTEX | 0.892 |
GAINL | 0.889 |
RMRM | 0.886 |
PROC | 0.886 |
WNW | 0.884 |
OP | 0.873 |
10 Most Negative Correlations | |
---|---|
SCR | -0.952 |
BOCH | -0.924 |
NETE | -0.919 |
KIN | -0.914 |
SHSP | -0.904 |
IPHA | -0.899 |
DGLY | -0.898 |
SRRA | -0.898 |
THCPU | -0.898 |
ICON | -0.895 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Vera Therapeutics, Inc. Correlation - Currency/Commodity
Vera Therapeutics, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $1.86M (0.00 %) |
EPS: | $-2.25 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $635 000 (0.00 %) |
EPS: | $-0.580 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.450 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.460 |
Financial Reports:
No articles found.
Vera Therapeutics, Inc.
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators